|
1
|
Smolen JS, Aletaha D, Barton A, Burmester
GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH,
Strand V and Yamamoto K: Rheumatoid arthritis. Nat Rev Dis Primers.
4(18001)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fang Q, Zhou C and Nandakumar KS:
Molecular and cellular pathways contributing to joint damage in
rheumatoid arthritis. Mediators Inflamm.
2020(3830212)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shevyrev D and Tereshchenko V: Treg
heterogeneity, function, and homeostasis. Front Immunol.
10(3100)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ehrenstein MR, Evans JG, Singh A, Moore S,
Warnes G, Isenberg DA and Mauri C: Compromised function of
regulatory T cells in rheumatoid arthritis and reversal by
anti-TNFalpha therapy. J Exp Med. 200:277–285. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Morita T, Shima Y, Wing JB, Sakaguchi S,
Ogata A and Kumanogoh A: The proportion of regulatory T cells in
patients with rheumatoid arthritis: A Meta-analysis. PLoS One.
11(e0162306)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang X, Zhang X, Zhuang L, Xu C, Li T,
Zhang G and Liu Y: Decreased regulatory T-cell frequency and
interleukin-35 levels in patients with rheumatoid arthritis. Exp
Ther Med. 16:5366–5372. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abazaa N, EL-kabarityb RH and Abo-Shadyb
RA: Deficient or abundant but unable to fight? Estimation of
circulating FoxP3+ T regulatory cells and their counteracting
FoxP3-in rheumatoid arthritis and correlation with disease
activity. Egypt Rheum. 35:185–192. 2013.
|
|
8
|
Walter GJ, Evans HG, Menon B, Gullick NJ,
Kirkham BW, Cope AP, Geissmann F and Taams LS: Interaction with
activated monocytes enhances cytokine expression and suppressive
activity of human
CD4+CD45ro+CD25+CD127low
regulatory T cells. Arthritis Rheum. 65:627–638. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kanjana K, Paisooksantivatana K,
Matangkasombut P, Chevaisrakul P and Lumjiaktase P: Efficient
short-term expansion of human peripheral blood regulatory T cells
for co-culture suppression assay. J Immunoassay Immunochem.
40:573–589. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Walter GJ, Fleskens V, Frederiksen KS,
Rajasekhar M, Menon B, Gerwien JG, Evans HG and Taams LS:
Phenotypic, functional, and gene expression profiling of peripheral
CD45RA+ and CD45RO+
CD4+CD25+CD127low treg cells in
patients with chronic rheumatoid arthritis. Arthritis Rheumatol.
68:103–116. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nie H, Zheng Y, Li R, Guo TB, He D, Fang
L, Liu X, Xiao L, Chen X, Wan B, et al: Phosphorylation of FOXP3
controls regulatory T cell function and is inhibited by TNF-α in
rheumatoid arthritis. Nat Med. 19:322–328. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang N, Schröppel B, Lal G, Jakubzick C,
Mao X, Chen D, Yin N, Jessberger R, Ochando JC, Ding Y and Bromberg
JS: Regulatory T cells sequentially migrate from inflamed tissues
to draining lymph nodes to suppress the alloimmune response.
Immunity. 30:458–469. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baecher-Allan C, Wolf E and Hafler DA: MHC
class II expression identifies functionally distinct human
regulatory T cells. J Immunol. 176:4622–4631. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shevyrev DV, Blinova EA and Kozlov VA: The
influence of humoral factors of homeostatic proliferation on
t-regulatory cells in vitro. Bull Siberian Med. 18:286–293.
2019.
|
|
15
|
Qureshi OS, Zheng Y, Nakamura K, Attridge
K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z,
et al: Trans-endocytosis of CD80 and CD86: A molecular basis for
the cell-extrinsic function of CTLA-4. Science. 332:600–603.
2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Basdeo SA, Moran B, Cluxton D, Canavan M,
McCormick J, Connolly M, Orr C, Mills KH, Veale DJ, Fearon U and
Fletcher JM: Polyfunctional, pathogenic CD161+ Th17
lineage cells are resistant to regulatory T cell-mediated
suppression in the context of autoimmunity. J Immunol. 195:528–540.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Komatsu N, Okamoto K, Sawa S, Nakashima T,
Oh-hora M, Kodama T, Tanaka S, Bluestone JA and Takayanagi H:
Pathogenic conversion of Foxp3+ T-cells into TH17 cells in
autoimmune arthritis. Nat Med. 20:62–70. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517.
2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ivanov II, McKenzie BS, Zhou L, Tadokoro
CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR: The orphan
nuclear receptor RORγt directs the differentiation program of
proinflammatory IL-17+ T helper cells. Cell.
126:1121–1133. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Aletaha D, Ward MM, Machold KP, Nell VP,
Stamm T and Smolen JS: Remission and active disease in rheumatoid
arthritis: Defining criteria for disease activity states. Arthritis
Rheum. 52:2625–2636. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
van der Heijde DM, van't Hof M, van Riel
PL and van de Putte LB: Development of a disease activity score
based on judgment in clinical practice by rheumatologists. J
Rheumatol. 20:579–581. 1993.PubMed/NCBI
|
|
22
|
Scott PJ and Huskisson EC: Measurement of
functional capacity with visual analogue scales. Rheumatol Rehabil.
16:257–259. 1977.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 Rheumatoid arthritis classification criteria:
An American College of Rheumatology/European League Against
Rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Böyum A: Isolation of leucocytes from
human blood. Further observations. Methylcellulose, dextran, and
ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest
Suppl. 97:31–50. 1968.PubMed/NCBI
|
|
25
|
Böyum A: Isolation of mononuclear cells
and granulocytes from human blood. Isolation of monuclear cells by
one centrifugation, and of granulocytes by combining centrifugation
and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 97:77–89.
1968.PubMed/NCBI
|
|
26
|
Collison LW and Vignali DA: In vitro Treg
suppression assays. Methods Mol Biol. 707:21–37. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mahmud SA, Manlove LS and Farrar MA:
Interleukin-2 and STAT5 in regulatory T cell development and
function. JAKSTAT. 2(e23154)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hua J, Inomata T, Chen Y, Foulsham W,
Stevenson W, Shiang T, Bluestone JA and Dana R: Pathological
conversion of regulatory T cells is associated with loss of
allotolerance. Sci Rep. 8(7059)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ivanov II, Zhou L and Littman DR:
Transcriptional regulation of Th17 cell differentiation. Semin
Immunol. 19:409–417. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tada Y, Ono N, Suematsu R, Tashiro S,
Sadanaga Y, Tokuda Y, Ono Y, Nakao Y, Maruyama A, Ohta A and
Koarada S: The balance between Foxp3 and Ror-γt expression in
peripheral blood is altered by tocilizumab and abatacept in
patients with rheumatoid arthritis. BMC Musculoskelet Disord.
17(290)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kugyelka R, Kohl Z, Olasz K, Mikecz K,
Rauch TA, Glant TT and Boldizsar F: Enigma of IL-17 and Th17 cells
in rheumatoid arthritis and in autoimmune animal models of
arthritis. Mediators Inflamm. 2016(6145810)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim BS, Lu H, Ichiyama K, Chen X, Zhang
YB, Mistry NA, Tanaka K, Lee YH, Nurieva R, Zhang L, et al:
Generation of RORγt+ Antigen-Specific T regulatory 17
cells from Foxp3+ precursors in autoimmunity. Cell Rep.
21:195–207. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rossetti M, Spreafico R, Consolaro A,
Leong JY, Chua C, Massa M, Saidin S, Magni-Manzoni S, Arkachaisri
T, Wallace CA, et al: TCR repertoire sequencing identifies synovial
Treg cell clonotypes in the bloodstream during active inflammation
in human arthritis. Ann Rheum Dis. 76:435–441. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dejaco C, Duftner C, Grubeck-Loebenstein B
and Schirmer M: Imbalance of regulatory T cells in human autoimmune
diseases. Immunology. 117:289–300. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lee GR: The Balance of Th17 versus Treg
cells in autoimmunity. Int J Mol Sci. 19(730)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Horwitz DA, Fahmy TM, Piccirillo CA and La
Cava A: Rebalancing immune homeostasis to treat autoimmune
diseases. Trends Immunol. 40:888–908. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shalini PU, Debnath T, Jvs V, Kona LK,
Kamaraju SR, Kancherla R and Chelluri LK: A study on FoxP3 and
Tregs in paired samples of peripheral blood and synovium in
rheumatoid arthritis. Cent Eur J Immunol. 40:431–436.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li N, Wei W, Yin F, Chen M, Ma TR, Wu Q,
Zhou JR, Zheng SG and Han J: The abnormal expression of CCR4 and
CCR6 on Tregs in rheumatoid arthritis. Int J Clin Exp Med.
8:15043–15053. 2015.PubMed/NCBI
|
|
39
|
Al-Banna NA, Vaci M, Slauenwhite D,
Johnston B and Issekutz TB: CCR4 and CXCR3 play different roles in
the migration of T cells to inflammation in skin, arthritic joints,
and lymph nodes. Eur J Immunol. 44:1633–1643. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Cribbs AP, Kennedy A, Penn H, Read JE,
Amjadi P, Green P, Syed K, Manka SW, Brennan FM, Gregory B and
Williams RO: Treg cell function in rheumatoid arthritis is
compromised by ctla-4 promoter methylation resulting in a failure
to activate the indoleamine 2,3-dioxygenase pathway. Arthritis
Rheumatol. 66:2344–2354. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Flores-Borja F, Jury EC, Mauri C and
Ehrenstein MR: Defects in CTLA-4 are associated with abnormal
regulatory T cell function in rheumatoid arthritis. Proc Natl Acad
Sci USA. 105:19396–19401. 2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Walker LS: Treg and CTLA-4: Two
intertwining pathways to immune tolerance. J Autoimmun. 45:49–57.
2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Linsley PS, Bradshaw J, Greene J, Peach R,
Bennett KL and Mittler RS: Intracellular trafficking of CTLA-4 and
focal localization towards sites of TCR engagement. Immunity.
4:535–543. 1996.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sansom DM: CD28, CTLA-4 and their ligands:
Who does what and to whom? Immunology. 101:169–177. 2000.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pesenacker AM, Bending D, Ursu S, Wu Q,
Nistala K and Wedderburn LR: CD161 defines the subset of
FoxP3+ T cells capable of producing proinflammatory
cytokines. Blood. 121:2647–2658. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Afzali B, Mitchell PJ, Edozie FC, Povoleri
GA, Dowson SE, Demandt L, Walter G, Canavan JB, Scotta C, Menon B,
et al: CD161 expression characterizes a subpopulation of human
regulatory T cells that produces IL-17 in a STAT3-dependent manner.
Eur J Immunol. 43:2043–2054. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Sato K, Suematsu A, Okamoto K, Yamaguchi
A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y,
et al: Th17 functions as an osteoclastogenic helper T cell subset
that links T cell activation and bone destruction. J Exp Med.
203:2673–2682. 2006.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Pappu BP and Dong C: Measurement of
interleukin-17. Curr Protoc Immunol: Chapter 6:Unit 6.25, 2007.
doi:10.1002/0471142735.im0625s79.
|
|
49
|
Zhao L, Chou Y, Jiang Y, Jiang Z and Chu
CQ: Analysis of IL-17 production by flow cytometry and ELISPOT
assays. Methods Mol Biol. 1172:243–256. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Wehrens EJ, Mijnheer G, Duurland CL, Klein
M, Meerding J, van Loosdregt J, de Jager W, Sawitzki B, Coffer PJ,
Vastert B, et al: Functional human regulatory T cells fail to
control autoimmune inflammation due to PKB/c-Akt hyperactivation in
effector cells. Blood. 118:3538–3548. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Herrath J, Müller M, Amoudruz P, Janson P,
Michaëlsson J, Larsson PT, Trollmo C, Raghavan S and Malmström V:
The inflammatory milieu in the rheumatic joint reduces regulatory
T-cell function. Eur J Immunol. 41:2279–2290. 2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zemmour D, Zilionis R, Kiner E, Klein AM,
Mathis D and Benoist C: Single-cell gene expression reveals a
landscape of regulatory T cell phenotypes shaped by the TCR. Nat
Immunol. 19:291–301. 2018.PubMed/NCBI View Article : Google Scholar
|
